로딩 중…
지수 로딩 중…
Alvotech
ALVO· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
IS
IS$3.92+0.00%
2026-06-18
Price Chart
Alvotech-56.49%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $1.22B |
| Revenue | $559M |
| Net Income | $-81M |
| Total Assets | $1.42B |
| Net Assets | $228M |
| Value | |
| P/B | 5.36x |
| P/S | 2.19x |
| FCF Yield | -14.01% |
| Profitability | |
| ROE | -35.38% |
| ROA | -5.68% |
| Op. Margin | 13.80% |
| Revenue Growth | -20.26% |
| Earnings Growth | -99.06% |
| Financial Health | |
| Debt Ratio | 746.46% |
| Total Debt | $1.46B |
| FCF | $-171M |
| Cash | $64M |
| Current Ratio | 1.76x |
| Performance | |
| 1Y Return | -56.49% |
| 1M Return | 19.51% |
| From 52W High | -60.56% |
| 1Y MDD | -72.90% |
| Trading | |
| Volume | 1,074,201 shares |
| Trading Value | $4M |
| Per Share | |
| EPS | $0.10 |